Global Demographic Shifts And Biotech Funding Will Fuel Outsourced R&D
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 17 Analysts
Published
03 Aug 25
Updated
20 Aug 25
AnalystHighTarget's Fair Value
CN¥138.00
27.6% undervalued intrinsic discount20 Aug
CN¥99.98
1Y
162.1%7D
3.1%1Y
162.1%7D
3.1%